Study of Efficacy and Safety of Nivolumab in Combination With EGF816 and of Nivolumab in Combination With INC280 in Patients With Previously Treated Non-small Cell Lung Cancer
Clinical trial NCT02323126 · TERMINATED
Trial details
- NCT number
- NCT02323126
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-02-09
- Primary completion
- 2019-09-23
- Enrollment
- 64
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.